Education
About Us
Working with TipRanks
Follow Us
Harrow Health Inc (HROW)
NASDAQ:HROW
Total Valuation
Harrow Health has a market cap or net worth of $1.11B. The enterprise value is $213.26M.
Market Cap$1.11B
Enterprise Value$213.26M
Share Statistics
Harrow Health has 36,699,554 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding36,699,554
Owned by Insiders26.08%
Owned by Institutions24.21%
Financial Efficiency
Harrow Health’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is 0.09%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)0.09%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee522.55K
Profits Per Employee-45.76B
Employee Count382
Asset Turnover0.51
Inventory Turnover4.60
Valuation Ratios
The current PE Ratio of Harrow Health is -68.42. Harrow Health’s PEG ratio is 1.20.
PE Ratio-68.42
PS Ratio0.00
PB Ratio14.88
Price to Fair Value<0.01
Price to FCF-66.80
Price to Operating Cash Flow237.73
PEG Ratio1.20
Income Statement
In the last 12 months, Harrow Health had revenue of 199.61M and earned -17.48M in profits. Earnings per share was -0.49.
Revenue199.61M
Gross Profit150.37M
Operating Income8.82M
Pretax Income-18.04M
Net Income-17.48M
EBITDA20.00M
Earnings Per Share (EPS)-0.49
Cash Flow
In the last 12 months, operating cash flow was 2.09M and capital expenditures -38.70M, giving a free cash flow of -36.61M billion.
Operating Cash Flow2.09M
Free Cash Flow-36.61M
Free Cash Flow per Share-1.00
Dividends & Yields
Harrow Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.78
52-Week Price Change71.34%
50-Day Moving Average26.08
200-Day Moving Average35.02
Relative Strength Index (RSI)60.05
Average Volume (3m)480.53K
Important Dates
Harrow Health upcoming earnings date is Aug 12, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 12, 2025
Ex-Dividend Date―
Financial Position
Harrow Health as a current ratio of <0.01, with Debt / Equity ratio of 382.43%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap0.18
Net Debt to EBITDA9.42
Interest Coverage Ratio0.39
Taxes
In the past 12 months, Harrow Health has paid -161.00B in taxes.
Income Tax-161.00B
Effective Tax Rate8.92K
Enterprise Valuation
Harrow Health EV to EBITDA ratio is 71.45, with an EV/FCF ratio of -22.63.
EV to Sales6.90
EV to EBITDA71.45
EV to Free Cash Flow-22.63
EV to Operating Cash Flow-62.05
Balance Sheet
Harrow Health has $66.73M in cash and marketable securities with $230.01M in debt, giving a net cash position of $163.28M billion.
Cash & Marketable Securities$66.73M
Total Debt$230.01M
Net Cash$163.28M
Net Cash Per Share$4.45
Tangible Book Value Per Share-$3.30
Margins
Gross margin is 71.35%, with operating margin of 4.42%, and net profit margin of -8.76%.
Gross Margin71.35%
Operating Margin4.42%
Pretax Margin-9.04%
Net Profit Margin-8.76%
EBITDA Margin9.66%
EBIT Margin2.74%
Analyst Forecast
The average price target for Harrow Health is $61.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$61.00
Price Target Upside101.25% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast53.49%
EPS Growth Forecast33.18%